HopeStage
Back to all studies
CompletedNCT04958460

BF688 for ADHD

It tested BF688 for ADHD.

ADHD, Probiotics, ...DrugFrom 4 Years to 16 Years
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 4 years to 16 years. Other eligibility criteria applied.

Listed locations
Kaohsiung City, TaiwanSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: May 14, 2020
Recruitment status
Completed
Enrollment listed in the registry
150
Sponsor
Wang Liang-Jen
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Taiwan
Age range
From 4 Years to 16 Years
Official registry ID
NCT04958460
Official title
Effect of Bifidobacterium Bifidum (Bf-688) on Clinical Characteristics and Gut Microbiota in Attention-deficit/Hyperactivity Disorder: a Double-blind Randomized-control Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Kaohsiung City

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wang Liang-Jen.

Did this study involve medication?

Yes. The study involved medication, including Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: 4 years to 16 years. Other eligibility criteria applied.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me